tiprankstipranks
Trending News
More News >
Spago Nanomedical AB (DE:7UX)
FRANKFURT:7UX
Germany Market

Spago Nanomedical AB (7UX) Income Statement

Compare
0 Followers

Spago Nanomedical AB Income Statement

Last quarter (Q4 2025), Spago Nanomedical AB's total revenue was kr4.00K, a decrease of -99.18% from the same quarter last year. In Q4, Spago Nanomedical AB's net income was kr-5.89M. See Spago Nanomedical AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 437.00Kkr 1.91Mkr 1.20Mkr 1.05Mkr 660.00K
Gross Profit
kr -19.38Mkr -12.36Mkr -23.28Mkr -15.60Mkr -16.78M
Operating Expenses
kr 11.48Mkr 26.10Mkr 24.49Mkr 25.32Mkr 22.29M
Depreciation and Amortization
kr 167.00Kkr 312.00Kkr 281.00Kkr 356.00Kkr 376.00K
EBITDA
kr -26.39Mkr -33.40Mkr -42.22Mkr -38.73Mkr -38.69M
Operating Income
kr -30.86Mkr -33.71Mkr -47.23Mkr -39.47Mkr -39.19M
Other Income/Expenses
kr 4.31Mkr 1.20Mkr 850.00Kkr 268.00Kkr 121.00K
Pretax Income
kr -26.55Mkr -32.51Mkr -42.22Mkr -39.20Mkr -39.07M
Net Income
kr -26.55Mkr -32.51Mkr -42.22Mkr -39.31Mkr -39.08M
Per Share Metrics
Basic EPS
kr -0.07kr -0.11kr -0.21kr -0.29kr -0.46
Diluted EPS
kr -0.07kr -0.11kr -0.21kr -0.29kr -0.46
Weighted Average Shares Outstanding
374.81M 295.42M 195.96M 133.62M 83.66M
Weighted Average Shares Outstanding (Diluted)
374.81M 295.42M 195.96M 190.43M 83.66M
Currency in SEK

Spago Nanomedical AB Earnings and Revenue History